Masonic Cancer Center, University Of Minnesota
Clinical trials sponsored by Masonic Cancer Center, University Of Minnesota, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Immune booster may strengthen stem cell transplant against hodgkin lymphoma Results expected Sep 2026 (estimated)
- Unlicensed cord blood units tested for safety in blood cancer patients Results expected Sep 2026 (estimated)
- New stem cell approach aims to beat lymphoma without radiation Results expected Sep 2026 (estimated)
- Double-Dose stem cell therapy shows promise for tough childhood cancer Results expected Oct 2026 (estimated)
- Can exercise tests reveal hidden health clues in childhood disease survivors? Results expected Nov 2026 (estimated)
-
Smartphone app aims to uncover food triggers for gut cancer survivors
Symptom relief Not yet recruitingThis study tests a mobile app called GutCheck for people who have survived gastrointestinal cancer. Participants track their diet, stress, and gut symptoms daily. The app analyzes the data to identify potential trigger foods. The goal is to see if the app is feasible and helpful …
Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
Could probiotics tame Chemo's worst symptoms?
Symptom relief Not yet recruitingThis study tests whether taking probiotic supplements can help reduce common chemotherapy side effects like nausea, diarrhea, and loss of appetite in people with stage III colon cancer. Forty adults will be randomly assigned to receive either probiotics or a placebo during their …
Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC